| __timestamp | ImmunityBio, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 2704597 |
| Thursday, January 1, 2015 | 11434000 | 15470000 |
| Friday, January 1, 2016 | 26546000 | 28037000 |
| Sunday, January 1, 2017 | 39778000 | 71615000 |
| Monday, January 1, 2018 | 53418000 | 99828000 |
| Tuesday, January 1, 2019 | 111997000 | 166023000 |
| Wednesday, January 1, 2020 | 139507000 | 201727000 |
| Friday, January 1, 2021 | 195958000 | 259039000 |
| Saturday, January 1, 2022 | 248149000 | 294781000 |
| Sunday, January 1, 2023 | 232366000 | 344077000 |
Cracking the code
In the competitive world of biotechnology, innovation is the lifeblood of success. ImmunityBio, Inc. and Iovance Biotherapeutics, Inc. have been at the forefront of this race, consistently investing in research and development (R&D) over the past decade. From 2014 to 2023, Iovance Biotherapeutics has shown a remarkable commitment to innovation, with R&D expenses growing by over 1,200%, peaking at approximately $344 million in 2023. In comparison, ImmunityBio's R&D spending increased by nearly 1,500%, reaching around $232 million in the same year. This trend highlights Iovance's slightly more aggressive approach, with their R&D expenses consistently surpassing ImmunityBio's by an average of 40% annually. As these companies continue to push the boundaries of medical science, their investments in innovation are not just numbers on a balance sheet but a testament to their dedication to transforming healthcare.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Lantheus Holdings, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: ImmunityBio, Inc. vs Travere Therapeutics, Inc.
Iovance Biotherapeutics, Inc. or MannKind Corporation: Who Invests More in Innovation?
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?